Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Leroy

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Clinics and Research in Hepatology and Gastroenterology|August 25, 2016
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)Hélène Fontaine, Marianne Maynard, Cécile Bouix, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosisMounira Kharoubi, Mélanie Bézard, Amaury Broussier, et al.
Transplantation Direct|June 24, 2022
Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac AmyloidosisSoulef Guendouz, Philippe Grimbert, Costin Radu, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2017
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access CohortKarine Lacombe, Hélène Fontaine, Catherine Dhiver, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantationJérôme Dumortier, Vincent Leroy, Christophe Duvoux, et al.
Plos One|August 4, 2022
Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trialAlexandra Audemard-Verger, Amélie Le Gouge, Vincent Pestre, et al.
The Lancet. Infectious Diseases|March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
JHEP Reports : Innovation in Hepatology|November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaGiuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Clinics and Research in Hepatology and Gastroenterology|August 25, 2016
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)Hélène Fontaine, Marianne Maynard, Cécile Bouix, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosisMounira Kharoubi, Mélanie Bézard, Amaury Broussier, et al.
Transplantation Direct|June 24, 2022
Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac AmyloidosisSoulef Guendouz, Philippe Grimbert, Costin Radu, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2017
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access CohortKarine Lacombe, Hélène Fontaine, Catherine Dhiver, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantationJérôme Dumortier, Vincent Leroy, Christophe Duvoux, et al.
Plos One|August 4, 2022
Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trialAlexandra Audemard-Verger, Amélie Le Gouge, Vincent Pestre, et al.
The Lancet. Infectious Diseases|March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
JHEP Reports : Innovation in Hepatology|November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaGiuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Pageof 18